Hyderabad, May 16: The price of COVID-19 vaccine Corbevax has been reduced to Rs 250 a dose from its earlier Rs 840, said Biological E Limited (BE) on Monday. For end-user, the price would be Rs 400 a dose, including taxes and administration charges, added the pharmaceutical company.
Earlier in April, the Drugs Controller General of India (DCGI) granted emergency use authorisation to Biological E's COVID-19 vaccine Corbevax for those aged 5 to 12 years, informed the pharmaceutical company. Corbevax is currently being administered to children in the age group of 12-14. Biological E's COVID-19 Vaccine Corbevax Gets Emergency Approval For 12-18 Age Group From DCGI.
Biological E Limited has manufactured 30 crore doses of Corbevax and has already supplied nearly 10 crore doses to the Central Government. Currently, over 3 crore doses of Corbevax have been administered to children between 12-15 years of age.
COVID-19 vaccination for minors in India started from January 3 onwards for those in the 15-18 age group with Bharat Biotech's Covaxin. The drive later expanded on March 16 to include children aged above 12 for Corbevax. India is currently administering two COVID-19 vaccines for children above 12.
(This is an unedited and auto-generated story from Syndicated News feed, LatestLY Staff may not have modified or edited the content body)